MAST1 and ovarian cancer: Recent research has revealed that microtubule-associated serine/threonine-protein kinase 1 (MAST1) plays an essential role in driving post-target cisplatin-resistance mechanisms in many cancers, including head and neck, lung, and ovarian cancers 8.